TGA okays first anti-amyloid Alzheimer’s drug

4 minute read


The intravenous infusion, which is yet to be considered for the PBS, will likely be restricted to tertiary facilities.


This content is for AHPRA registered professionals only.
Join Now

End of content

No more pages to load

Log In Register ×